Joshua Riggs - Insight Molecular CEO President
| IMDX Stock | 5.82 0.41 7.58% |
CEO
Joshua Riggs is CEO President of Insight Molecular Diagnostics
| Age | 42 |
| Address | 2 International Plaza Dr., Nashville, TN, United States, 37217 |
| Phone | 949 409 7600 |
| Web | https://imdxinc.com |
Insight Molecular Management Efficiency
The company has return on total asset (ROA) of (0.2217) % which means that it has lost $0.2217 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.2896) %, meaning that it created substantial loss on money invested by shareholders. Insight Molecular's management efficiency ratios could be used to measure how well Insight Molecular manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 5.19 in 2025, despite the fact that Return On Tangible Assets are likely to grow to (2.81). At this time, Insight Molecular's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 32.8 M in 2025, despite the fact that Return On Tangible Assets are likely to grow to (2.81).Similar Executives
| Found 7 records | CEO Age | ||
| Heidi MS | Invivyd | N/A | |
| Andrew MBA | C4 Therapeutics | 54 | |
| John Nicols | Codexis | 60 | |
| Deborah MD | Armata Pharmaceuticals | 68 | |
| Joseph MBA | Milestone Pharmaceuticals | 57 | |
| Matthew Foehr | OmniAb Inc | 52 | |
| Stephen MBBS | Codexis | 65 | |
Management Performance
| Return On Equity | -4.29 | ||||
| Return On Asset | -0.22 |
Insight Molecular Leadership Team
Elected by the shareholders, the Insight Molecular's board of directors comprises two types of representatives: Insight Molecular inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Insight. The board's role is to monitor Insight Molecular's management team and ensure that shareholders' interests are well served. Insight Molecular's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Insight Molecular's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gabrielle Woody, Executive Assistant | ||
| Andrea James, Chief Officer | ||
| James Liu, Treasurer, Accounting | ||
| Joshua Riggs, CEO President | ||
| Ekkehard MD, Chief Officer | ||
| Michael West, CoCEO Advisor | ||
| YuhMin Chiang, Chief Officer | ||
| Peter Hong, General VP | ||
| FACP MD, Consulting Officer | ||
| MD FACP, Consulting Officer | ||
| Sandra ODonald, Senior Operations |
Insight Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Insight Molecular a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.29 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (2.73) % | ||||
| Current Valuation | 54.24 M | ||||
| Shares Outstanding | 28.6 M | ||||
| Shares Owned By Insiders | 22.03 % | ||||
| Shares Owned By Institutions | 56.30 % | ||||
| Number Of Shares Shorted | 146.31 K | ||||
| Price To Book | 8.00 X | ||||
| Price To Sales | 22.55 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.